Tax receivable agreements (TRAs), explained
A tax receivable agreement, or TRA, is a contractual arrangement where a company agrees to share future tax savings with pre-IPO shareholders (often the private equity sponsor and the pre-IPO founders or managers). When a PE-backed company does an IPO using an "Up-C" structure, the IPO creates future tax deductions for the public company. Normally those deductions would reduce the public company's future tax bills, benefiting all public shareholders. Under a TRA, the public company agrees to pay ~85% of those tax savings, as they are realised, back to the pre-IPO shareholders. TRAs have become common in PE-to-IPO exits over the past 10 years. They are also one of the least-understood and most value-extractive structures in the public markets, because most retail investors reading the IPO prospectus have no idea what they mean.
That is the textbook answer. Here is what actually happens.
The Up-C structure
To understand TRAs, you have to understand the Up-C structure that makes them possible.
In a traditional IPO, the company whose shares are being sold to the public is the operating company. Everyone owns shares in the same legal entity.
In an Up-C IPO, there are two legal entities:
- The operating partnership. Usually an LLC or partnership. This is where the actual business operates. Pre-IPO owners (the PE firm, the founders, management) own units in this partnership.
- The public company. A corporation that sells shares to the public in the IPO. The public company owns a share of the operating partnership (often a majority share).
The pre-IPO owners retain their direct partnership units. The public shareholders own shares of the public company, which in turn owns a partnership interest.
This dual-entity structure has tax advantages for the pre-IPO owners. Over time, the pre-IPO owners can "exchange" their partnership units for public company shares (a transaction that creates taxable income for them, but also steps up the tax basis of the public company's assets). Each exchange creates new depreciation and amortisation deductions for the public company, reducing its future tax bill.
Where the TRA comes in
The key insight of the TRA: those future tax deductions, generated by pre-IPO owners exchanging their units, are worth real money.
Over the life of a typical Up-C company, the stepped-up basis deductions might reduce the public company's tax bill by $500 million to $2 billion, spread over 15-20 years.
Without a TRA, the public company keeps all those tax savings. Shareholders benefit from higher after-tax earnings.
With a TRA, the public company agrees to pay approximately 85% of those realised tax savings back to the pre-IPO owners who caused the deductions to exist. The public company keeps 15% for itself.
From the pre-IPO owners' perspective, this is a second wave of value extraction. They already got their IPO proceeds. They also get 85% of the tax savings generated by the future exchanges they will make.
From the public shareholders' perspective, this is a drag on earnings. The benefit of the tax deductions flows to the pre-IPO owners, not to them.
The history
TRAs emerged in the 1990s as a way to structure deals between pre-IPO owners and public companies in specific tax-sensitive situations.
Their use exploded in the 2010s as Up-C structures became standard in PE-backed IPOs. The logic was: the pre-IPO owners are doing the public shareholders a favor by structuring the deal as an Up-C (enabling the tax deductions in the first place). The TRA compensates them for that favor by giving them most of the upside.
Over time, TRAs became contractual boilerplate in PE-to-IPO deals. Almost every PE-backed IPO using an Up-C structure now includes a TRA.
Critics argue that the TRA compensates pre-IPO owners for something the public shareholders did not negotiate for and do not understand. Supporters argue that without the TRA, the deal would not happen in that form, and public shareholders implicitly benefit from the overall structure anyway.
Both arguments have merit. The question is whether public shareholders are paying too much for the structural benefit.
How a TRA actually works in practice
Consider a PE-backed company going public.
Pre-IPO: PE firm owns 80% of the operating partnership. Management owns 20%.
IPO: The public company is created, sells 30% of itself to public shareholders, and uses the IPO proceeds to buy 30% of the operating partnership from the PE firm. PE firm goes from 80% of the operating partnership to roughly 56% (of a now-larger base). Management still owns 20%.
The TRA is signed between the public company and the PE firm (and management).
Over the next 15 years: The PE firm gradually exchanges its 56% partnership stake for public company shares. Each exchange creates depreciation and amortisation deductions. The public company's tax bill is reduced.
Under the TRA: Each time the public company realises those tax savings (usually determined year by year based on actual tax returns), it pays 85% of those savings to the PE firm. Some companies have structured TRAs with accelerated payment schedules that pay the PE firm present-value equivalents upfront. Others pay annually as the savings materialise.
For a large PE-to-IPO deal, TRA payments to the PE sponsor over the life can run into several hundred million dollars. This is cash flowing from the public company to the PE firm and other pre-IPO owners, reducing the public company's free cash flow available to public shareholders.
Why TRAs are controversial
Three reasons.
Opacity. Most retail investors, and a meaningful share of institutional investors, do not fully understand TRAs when they read IPO prospectuses. The complexity is such that even tax specialists need time to work through the numbers. A retail investor buying into a PE-backed IPO may not realise that 85% of a significant future tax benefit is flowing to the pre-IPO seller.
Payment timing. TRAs can create meaningful cash outflows for the public company in years when its other financial metrics are strong. A growth company that is otherwise cash-generative might be paying $50-100m a year in TRA obligations, which reduces reported free cash flow.
Alignment misincentive. In some structures, the TRA creates incentives for the PE firm to continue exchanging units (to trigger more deductions and more TRA payments), even when doing so is not in the public company's interest from a corporate-strategy perspective.
When TRAs are reasonable
Despite the concerns, TRAs can be defensible in specific scenarios.
When the Up-C structure meaningfully benefits public shareholders. If the structure enables a lower effective tax rate for the consolidated business that materially exceeds what the public company would achieve on its own, the TRA is splitting a real surplus. The pre-IPO owners get most of it; the public shareholders get some of it.
When the TRA is fully disclosed. A well-disclosed TRA, with clear explanations of the economic impact and the expected magnitude, lets investors price the structure into the IPO. If the market is pricing in the TRA, public shareholders are not being fooled.
When the TRA reflects specific negotiation. If the pre-IPO owners gave up something to get the TRA (perhaps lower IPO valuation, or accepted longer lockups), the TRA is compensating them for those concessions.
The 2025/2026 picture
TRAs have been under increasing scrutiny.
SEC disclosure requirements have gradually gotten more demanding. IPO prospectuses now include detailed TRA disclosures, including estimated future payments. This is progress, though the complexity still limits how useful the disclosures are to most investors.
Institutional investor pushback has grown. Some large asset managers now explicitly scrutinise TRA terms in PE-backed IPOs and have declined to participate in some deals where the terms were particularly aggressive.
Activist investors have in some cases pushed public companies to renegotiate or terminate TRAs. This has created interesting litigation about whether a company can unilaterally modify a TRA.
Private equity firms have continued to use TRAs because they are value-accretive. The pushback has been marginal, not structural.
How to read a TRA in an IPO prospectus
When you see a PE-backed IPO, the useful questions are:
What is the total expected TRA payment over the structure's life? This is usually disclosed in the prospectus as a range. If the high end is 10%+ of the IPO market cap, the TRA is material.
What is the annual TRA cash flow expected? This is the drag on ongoing free cash flow. A $50m annual TRA obligation on a company with $200m of free cash flow is a 25% haircut.
Is the TRA payment accelerated on change of control? Many TRAs have provisions that accelerate the payment if the company is acquired. This can materially affect acquisition economics.
Is the percentage 85% or different? 85% is the standard. Higher percentages are more extractive; lower are more shareholder-friendly.
The closing take
TRAs are one of the quieter value-transfer mechanisms in PE-to-IPO deals. They compensate pre-IPO owners for structural contributions (the Up-C tax-deduction enablement) that most retail investors do not fully understand.
They are not inherently unfair. In a world where PE firms have negotiating leverage and structural expertise, extracting 85% of Up-C-derived tax savings is a rational thing for them to do. The deal terms reflect who has leverage.
For public shareholders, the lesson is to read the prospectus. A PE-backed IPO that mentions an Up-C structure and a TRA has something material worth understanding. The IPO price should reflect the TRA drag; if it does not, the investors buying in are paying for value that flows elsewhere.
For the broader picture of how PE firms exit deals, see what is private equity. For other structures PE firms use to extract value from portfolio companies, see dividend recapitalisations, sale-leasebacks, and the rest of the toolkit.
